Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.8K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High ALG1 Expression Is Correlated With Poor Prognosis and the Immune Microenvironment in Glioma.

Journal of cellular and molecular medicine·2026
Same author

Continuous high-frequency deep brain stimulation of the anterior insula modulates autism-like behavior in a valproic acid-induced rat model.

Journal of translational medicine·2022
See all related articles

Related Experiment Video

Updated: May 6, 2026

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism
08:44

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism

Published on: October 17, 2025

861

Prefrontal Cortex 5-HT1A Receptor-Coupled Inwardly Rectifying Potassium Channels Decreased Seizure Susceptibility in

Zhuoqi Li1,2,3, Yangyang Sun1,2, Xianhao Huo1

  • 1Department of Neurosurgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China, nxmu.edu.cn.

Neural Plasticity
|May 5, 2026
PubMed
Summary

Activating serotonin 1A receptors (5-HT1A) in the prefrontal cortex reduced epilepsy risk in an autism spectrum disorder (ASD) rat model. This effect was mediated by Kir3 channels, suggesting new therapeutic targets for co-occurring ASD and epilepsy.

Keywords:
5-HT1A receptorautism spectrum disorderexcitatory/inhibitory imbalanceinwardly rectifying potassium channelprefrontal cortexseizure susceptibility

More Related Videos

Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

34.2K
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

11.8K

Related Experiment Videos

Last Updated: May 6, 2026

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism
08:44

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism

Published on: October 17, 2025

861
Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

34.2K
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

11.8K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Developmental Neuroscience

Background:

  • Serotonin 1A receptor (5-HT1A) dysregulation is linked to autism spectrum disorder (ASD) and epilepsy.
  • The prefrontal cortex (PFC) is crucial for neuronal development and epilepsy susceptibility.
  • Valproic acid (VPA) exposure can induce autism-like behaviors and alter PFC development in rats.

Purpose of the Study:

  • To investigate the anticonvulsant effects of activating PFC 5-HT1A receptors in a VPA-induced rat model of ASD.
  • To explore the role of Kir3 channels in mediating these anticonvulsant effects.
  • To assess potential therapeutic targets for epilepsy associated with ASD.

Main Methods:

  • Induced autism-like behaviors in rats via prenatal VPA exposure.
  • Assessed seizure susceptibility using pentylenetetrazol (PTZ)-induced chemical kindling.
  • Administered 8-OH-DPAT (a 5-HT1A agonist) and tertiapin-Q (a Kir3 channel blocker) to evaluate effects on neuronal activity and seizures.

Main Results:

  • VPA-induced ASD rats showed increased epilepsy susceptibility, characterized by reduced seizure latency and prolonged seizure duration.
  • 8-OH-DPAT treatment significantly attenuated seizure activity and reduced neuronal excitability (decreased spontaneous action potential and miniature excitatory postsynaptic current frequencies).
  • The anticonvulsant effects of 8-OH-DPAT were diminished by tertiapin-Q, indicating the involvement of Kir3 channels.

Conclusions:

  • Activation of PFC 5-HT1A receptors exerts anticonvulsant effects in an ASD rat model.
  • Kir3 channels mediate the hyperpolarization responsible for 8-OH-DPAT's anticonvulsant actions.
  • 5-HT1A receptors and Kir3 channels represent potential therapeutic targets for managing epilepsy in individuals with ASD.